Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Duffy has more than 30 years’ experience in the industry.
October 27, 2021
By: Charlie Sternberg
Abzena, a Partner Research Organization (PRO) for outsourced solutions integrating gene to commercial for large molecules and bioconjugates, has promoted Dr. Louise Duffy as chief technical officer. Reporting to Kimball Hall, president and chief operating officer, and complimenting the operational and technical leadership team, Duffy focuses on scientific quality and operational timelines to ensure that integrated biologics projects for Abzena’s customers achieve successful IND or BLA outcomes. Duffy provides support to the company in GMP infrastructure, technology design and operational manufacturing support. Duffy commented, “I am pleased to have the opportunity to support Abzena’s continue growth and success. I am delighted to spearhead technology strategy and implementation as we expand our GMP capabilities.” Dr. Jonathan Goldman MD, CEO of Abzena commented, “We are pleased to announce Louise’s promotion. She has brought exceptional experience in science and leadership to Abzena. Abzena delivers fully integrated gene to GMP manufacturing in biologics, complex large molecules and bioconjugation, including antibody drug conjugates under one roof. We have shown great success in transitioning complex molecules through lead selection into clinical development in multiple therapeutic areas. Louise’s expertise has enhanced our client partner’s experience.” Duffy has more than 30 years’ experience in the industry, including increasing responsibilities at GlaxoSmithKline and Janssen. Prior to joining Abzena almost two years ago, she was an independent consultant in biopharmaceuticals and cell and gene therapies. Duffy has developed strategic CMC plans to support regulatory filings such as INDs, IMPDs, BLA, MAAs. Duffy received both her Doctorate in Chemical Engineering and MSc in Advanced Chemical Engineering from Imperial College in London, UK and her BSc (Hons) in Chemistry and Biochemistry from the University of British Columbia.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !